AI assistant
Sending…
RESMED INC — Director's Dealing 2024
May 10, 2024
30071_dirs_2024-05-10_f9ef766b-3f3b-492b-8428-122a2cde9c21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-05-08
Reporting Person: Sandercock Brett (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-08 | ResMed Common Stock | M | 12000 | $101.64 | Acquired | 105056 | Direct |
| 2024-05-08 | ResMed Common Stock | S | 13000 | $211.37 | Disposed | 92056 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-08 | ResMed Common Stock Options | $101.64 | M | 12000 | Disposed | 2025-11-14 | ResMed Common Stock (12000) | Direct |
Footnotes
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 8, 2024.
F2: Includes 94.177 shares of ResMed stock purchased on April 30, 2024, through the ResMed Employee Stock Purchase Plan.
F3: Represents date options first became exercisable. Options vest 1/3 per year.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29